<DOC>
	<DOC>NCT00114686</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with Quetiapine Fumarate (SEROQUEL) in conjunction with mood stabilizers (Lithium or Divalproex) for 12 weeks helps patients who have Bipolar I Disorder with Alcohol Dependence</brief_summary>
	<brief_title>Efficacy and Safety of Quetiapine Fumarate (SEROQUELÂ®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Meets criteria for Bipolar I Disorder with Alcohol dependence Outpatient Status Recent history of heavy drinking Unstable medical illness Recent antipsychotic use Poorly controlled Diabetes Mellitus or Diabetes related illness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar I Disorder</keyword>
	<keyword>Alcohol Dependency</keyword>
</DOC>